Atara Biotherapeutics, Inc. (ATRA) › Total AssetsAtara Biotherapeutics, Inc. (ATRA) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $51.83M2014: $106.12M2015: $324.98M2016: $263.91M2017: $217.78M2018: $391.84M2019: $342.94M2020: $588.12M2021: $468.13M2022: $376.42M2023: $165.50M2024: $109.10M2025: $20.23M$20.23M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$20.23M-81.5%2024$109.10M-34.1%2023$165.50M-56.0%2022$376.42M-19.6%2021$468.13M-20.4%2020$588.12M+71.5%2019$342.94M-12.5%2018$391.84M+79.9%2017$217.78M-17.5%2016$263.91M-18.8%2015$324.98M+206.2%2014$106.12M+104.8%2013$51.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share